Sharing Dark Data: Inside The ATOM Initiative
Executive Summary
Data sharing initiative ATOM, of which GlaxoSmithKline is a member, wants to cut the time it takes to get from concept to molecule through comprehensive data sharing. John Baldoni, founder of ATOM and co-chair of its governing board, talks to Scrip about the consortium’s goals and bringing other big pharmas on board.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.